Psychiatry Investig > Volume 21(4); 2024 > Article |
|
Availability of Data and Material
The datasets generated or analyzed during the study are not publicly available due the possible infringement of data privacy, but are available from the corresponding author on reasonable request.
Conflicts of Interest
The authors have no potential conflicts of interest to disclose.
Author Contributions
Conceptualization: In Won Chung, Yong Sik Kim, Seong Hoon Jeong. Data curation: Nam Young Lee, Hee Yeon Jeong. Formal analysis: Sang Won Park, Seong Hoon Jeong. Investigation: Nam Young Lee, Hee Yeon Jeong. Methodology: Nam Young Lee, In Won Chung, Seong Hoon Jeong. Project administration: Sang Won Park, Nam Young Lee. Resources: Sang Won Park, In Won Chung. Software: Seong Hoon Jeong. Supervision: Yong Sik Kim, Seong Hoon Jeong. Validation: Sang Won Park, Seong Hoon Jeong, Yong Sik Kim. Visualization: Sang Won Park, Seong Hoon Jeong. Writing—original draft: Sang Won Park, Seong Hoon Jeong. Writing—review & editing: Sang Won Park, Seong Hoon Jeong.
Funding Statement
None
Male (N=36) | Female (N=47) | Total (N=83) | p* | |
---|---|---|---|---|
Age (yr) | 35.9±9.9 | 38.1±11.0 | 37.2±10.6 | 0.353 |
Clozapine use | 9 (25.0) | 17 (36.2) | 26 (31.3) | 0.396 |
Hallucinatory experience | ||||
HPSVQ | ||||
Physical | 13.4±5.4 | 12.4±4.7 | 12.8±5.0 | 0.387 |
Emotional | 9.2±4.1 | 7.6±3.3 | 8.3±3.8 | 0.044 |
Total | 22.6±8.6 | 20.0±7.4 | 21.1±8.0 | 0.137 |
PSYRATS | ||||
Physical | 6.8±4.7 | 6.7±3.6 | 6.7±4.1 | 0.939 |
Emotional | 6.0±4.8 | 4.3±4.5 | 5.0±4.7 | 0.107 |
Cognition | 7.2±4.9 | 7.0±4.1 | 7.1±4.5 | 0.879 |
Total | 16.1±12.6 | 14.1±10.3 | 15.0±11.4 | 0.445 |
Level of insight | ||||
VAGUS-SR | ||||
Awareness | 5.7±2.5 | 4.8±2.8 | 5.2±2.7 | 0.128 |
Attribution | 4.9±1.5 | 4.6±1.5 | 4.7±1.5 | 0.435 |
Need for treatment | 6.8±2.4 | 6.2±2.4 | 6.4±2.4 | 0.250 |
Total | 23.3±7.0 | 20.4±6.8 | 21.7±7.0 | 0.067 |
VAGUS-CR | ||||
Awareness | 6.2±3.0 | 5.9±3.0 | 6.0±3.0 | 0.609 |
Attribution | 5.4±2.7 | 5.6±2.8 | 5.5±2.8 | 0.773 |
Need for treatment | 8.2±2.5 | 6.5±3.1 | 7.2±2.9 | 0.011 |
Total | 25.8±8.0 | 24.1±9.1 | 24.8±8.7 | 0.387 |
Accompanying symptoms | ||||
PANSS | ||||
Positive | 13.3±3.7 | 12.3±4.2 | 12.8±4.0 | 0.278 |
Negative | 18.9±5.5 | 16.1±5.6 | 17.3±5.7 | 0.027 |
Anxiety/depression | 10.1±3.8 | 8.2±3.1 | 9.0±3.5 | 0.015 |
χ² | df | p | CFI | RMSEA | RMSEA p | AIC | BIC | |
---|---|---|---|---|---|---|---|---|
Self-report | 17.505 | 16 | 0.354 | 0.993 | 0.034 | 0.565 | 3,287.803 | 3,355.531 |
Clinician-rated | 17.569 | 16 | 0.350 | 0.993 | 0.034 | 0.561 | 3,445.870 | 3,513.598 |
Both data showed adequate fit. Therefore, it can be concluded that the model was invariant to data source (self-report or clinician-rated).
SEM, Structural Equation Modeling; χ², chi square distribution; df, degree of freedom; CFI, comparative fit index; RMSEA, root mean square error of approximation; RMSEA p, p-value of root mean square error of approximation; AIC, Akaike’s information criterion; BIC, Bayesian information criterion
The sequential restriction from “no grouping” to “equal regression coefficients” produced no significant deterioration in the model fit from less restricted model. Therefore, it can be concluded that the model was invariant to data source (self-report or clinician-rated). SEM, Structural Equation Modeling; χ2, chi square distribution; df, degree of freedom; CFI, comparative fit index; RMSEA, root mean square error of approximation; AIC, Akaike’s information criterion; BIC, Bayesian information criterion